Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) today announced that Janssen Pharmaceuticals, Inc., has approved its wholly owned subsidiary, Canabo Medical Inc. as an administrator…

Aleafia Health Inc. (TSX: AH, OTC: ALEAF) today announced that Janssen Pharmaceuticals, Inc., has approved its wholly owned subsidiary, Canabo Medical Inc. as an administrator and prescriber of antidepressant SPRAVATO® (esketamine) nasal spray. Three Canabo clinics, including the Company’s flagship Toronto location, along with a growing number of clinic network physicians and nurses, are now […]

The post Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO® appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *